VP, Biomarkers and Companion Diagnostics @ (January 2019 - May 2022)
VP Translational Medicine, Biomarkers and Diagnostics @ (January 2014 - December 2018)
Global Head, Clinical Biomarkers @ (January 2008 - July 2013)
Director of Laboratories @ LipoScience (January 2007 - January 2008)
Assistant Director and Technical Manager of Laboratories @ (January 2003 - January 2007)
Assistant Professor and Associate Director of the Surgical Immunology Lab @ (January 1999 - January 2003)
Research Associate @ (January 1998 - January 1999)
Postdoctoral Fellow @ Tulane Medical Center (January 1996 - January 1997)
Abdel Halim Education
Bonn University (Germany), Cairo University (Egypt)
PhD (Biochemistry (Molecular Biology and Tumor Biomarkers))
Abdel Halim Skills
Clinical Trials
Pharmaceutical Industry
Assay Development
Biotechnology
Biomarkers
Precision medicine
Companion diagnostics
Translational medicine
Clinical laboratory
IVD
Clinical development
Oncology
Cardiovascular
Abdel Halim Summary
Abdel Halim, based in United States, is currently a CEO and CSO at Wren Laboratories. Abdel Halim brings experience from previous roles at KOL/Advisor, Acutis Diagnostics, TAIHO ONCOLOGY INC and Celldex Therapeutics. Abdel Halim holds a PhD in Biochemistry (Molecular Biology and Tumor Biomarkers) @ Bonn University (Germany), Cairo University (Egypt). With a robust skill set that includes Clinical Trials, Pharmaceutical Industry, Assay Development, Biotechnology, Biomarkers and more. Abdel Halim has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Abdel Halim?
Find contact details for 700 million professionals.